BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity.
about
Current and emerging treatment options for hairy cell leukemiaClinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyondTargeting Mutant BRAF in Relapsed or Refractory Hairy-Cell LeukemiaRemoving a hair of doubt about BRAF targeting.The distribution of BRAF gene fusions in solid tumors and response to targeted therapy.Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.Molecular deregulation of signaling in lymphoid tumors.Potential role of AKT/mTOR signalling proteins in hairy cell leukaemia: association with BRAF/ERK activation and clinical outcome.Potential breakthroughs with investigational drugs for hairy cell leukemia.Hairy cell leukemia: Past, present and future.Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets.How I manage patients with hairy cell leukaemia.Small molecules against B-RAF (BRAF) Val600Glu (V600E) single mutationGenomics of Hairy Cell Leukemia.Recent advances in understanding and managing hairy cell leukemia.
P2860
Q26796423-79F4D116-C4D8-4989-87D0-2EFD92D002ADQ27027493-B89C9B71-24C2-4496-9F42-6640DB7F638CQ27853209-D42C9D70-E42F-4B81-90A5-206EE23B9D09Q35103523-F6D5E74F-F015-42CA-A651-0A4F5D66C99FQ37308973-2825243D-2D91-486A-B798-4595A3790A31Q37623386-36AADBD3-681C-4A3F-80DE-838E09329A33Q38424403-5D720202-40D2-4FD6-A487-AD50463863A8Q38555962-56EC7C1D-A855-460F-8F8C-DDE0BA8B1FF8Q38578492-B97E7E61-A215-47BA-8979-47D26A325BFDQ38651453-38528E55-7F37-4140-9304-A35019DC6D9FQ38819164-671F7F79-3673-4F0E-9E97-313929E4AC87Q39113513-85C2D4ED-051E-4011-B9A5-AD4C4175EB70Q42424413-340A1583-1C85-4A6C-8D57-A8C785FF53FAQ52781884-E822813A-010E-4E97-9F3D-7341EBEE5C59Q55396457-B468A06C-B256-4482-A6D4-377C9518C720
P2860
BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
BRAF inhibitors reverse the un ...... potent antileukemic activity.
@en
BRAF inhibitors reverse the un ...... potent antileukemic activity.
@nl
type
label
BRAF inhibitors reverse the un ...... potent antileukemic activity.
@en
BRAF inhibitors reverse the un ...... potent antileukemic activity.
@nl
prefLabel
BRAF inhibitors reverse the un ...... potent antileukemic activity.
@en
BRAF inhibitors reverse the un ...... potent antileukemic activity.
@nl
P2093
P2860
P50
P1433
P1476
BRAF inhibitors reverse the un ...... potent antileukemic activity.
@en
P2093
Alessandra Pucciarini
Alessia Santi
Ariele Spanhol-Rosseto
Barbara Bigerna
Elisa Imperi
Elisabetta Fortini
Enrico Tiacci
Guido Russo
Ludger Klein-Hitpass
Maria Paola Martelli
P2860
P304
P356
10.1182/BLOOD-2014-10-603100
P407
P577
2014-12-05T00:00:00Z